CIK 0001745999
- Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Option exercise President & CSO acquired 4,030 shares (option exercise)
- 4 Grant or award CFO acquired 17,500 shares (grant or award)
- 4 Other disposition Director disposed of 400,000 shares (other)
- 4 Other disposition Director disposed of 400,000 shares (other)
- 4 Other disposition 10% owner disposed of 400,000 shares (other)
- 4 Other disposition Director disposed of 800,000 shares (other)
- 4 Other disposition Director disposed of 800,000 shares (other)
- 4 Other disposition 10% owner disposed of 800,000 shares (other)
- 4 Other acquisition 10% owner acquired 356,673 shares (other)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CFO sold 25,000 shares at an average $81.78 ($2,044,485)
- 4 Open-market sale President & CSO sold 43,842 shares at an average $83.26 ($3,650,144)
- 4 Open-market sale CEO sold 22,300 shares at an average $84.94 ($1,894,125)
- 4 Option exercise President & CSO acquired 3,731 shares (option exercise)
- 4 Option exercise CFO acquired 7,309 shares (option exercise)
- 4 Option exercise CEO acquired 115,000 shares (option exercise)
- 4 Other acquisition 10% owner acquired 356,674 shares (other)
- 4 Conversion 10% owner acquired 6,971,912 shares (conversion)
- 4 Conversion 10% owner acquired 1,161,458 shares (conversion)
Page 11 of 12 · 238 filings